2010
DOI: 10.1016/j.diagmicrobio.2009.12.015
|View full text |Cite
|
Sign up to set email alerts
|

Erratum to “Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin” [Diagn Microbiol Infect Dis 65 (2009) 188–191]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
18
0
2

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 0 publications
0
18
0
2
Order By: Relevance
“…Hawley et al [4] detected 100% heteroresistance among 21 patients in the United States. Later, in their studies in Argentine, Rodriguez et al [19] Rodriguez et al [20] have found 46% and 43% heteroresistance rates in 2009 and 2010, respectively. In their case report, Moosavian et al [10] have recently demonstrated post neurosurgical meningitis due to colistin heteroresistant A. baumannii.…”
Section: Discussionmentioning
confidence: 99%
“…Hawley et al [4] detected 100% heteroresistance among 21 patients in the United States. Later, in their studies in Argentine, Rodriguez et al [19] Rodriguez et al [20] have found 46% and 43% heteroresistance rates in 2009 and 2010, respectively. In their case report, Moosavian et al [10] have recently demonstrated post neurosurgical meningitis due to colistin heteroresistant A. baumannii.…”
Section: Discussionmentioning
confidence: 99%
“…Colistin resistance among Acinetobacter strains, especially in A. baumannii, is increasing. In different parts of the world such as France (26), Argentina (27), Spain (28), Kuwait (29), and India (30), colistin-resistant Acinetobacter strains have been identified. There has been only one case of colistin-resistant Acinetobacter infection reported from Turkey (24).…”
Section: Discussionmentioning
confidence: 99%
“…Nephrotoxicity is a major concern when colistin is administered in patients with a history of chronic renal failure 17 . Colistin combination therapy is being strongly recommended against monotherapy due to selection of heteroresistant strains during prolonged colistin therapy 22 and heteroresistance strains were reported to be correlated with endemic infections in ICU 23 . Thus combination therapy might be beneficial for clinicians to prevent the emergence of resistance during therapy, decreased nephrotoxicity, especially if therapeutic options are limited.…”
Section: Discussionmentioning
confidence: 99%